Valacyclovir is a generic prescription oral tablet used to treat herpes simplex infections. Its mechanism of action is to make it harder for the herpes virus to multiply. The herpes virus spreads in ...

May 25, 2010 -- Sandoz today announced the introduction in the US of valacyclovir hydrochloride (HCl) tablets, a generic equivalent of Valtrex. Valacyclovir HCl tablets are indicated for treatment of ...

May 19, 2004 (Boston) — Valacyclovir is equally as effective as ganciclovir in preventing cytomegalovirus (CMV) in renal transplantation, and it may be more cost-effective as well, researchers ...

Research Triangle Park, N.C., January 1, 2004 – GlaxoSmithKline today announced the publication of results from a clinical trial evaluating VALTREX® (valacyclovir HCl), an oral antiviral, in the ...

Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...

New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with ...

Co announces it has received tentative approval for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500mg and 1000mg. Valacyclovir Hydrochloride Tablets are the generic ...

August 24, 2010 — Exposure to acyclovir or valacyclovir in the first trimester of pregnancy is not associated with an increased risk for major birth defects, according to the results of a large, ...

The Indian Patent Office has granted patent to Aurobindo Pharma for its process for the preparation of its antiviral drug valacyclovir, which has been sold in US and other countries under the trade ...

Ranbaxy Laboratories announces it has reached an agreement with GlaxoSmithKline (GSK) resulting in a dismissal of their U.S. litigation with regard to Valtrex. The lawsuit in the U.S. was related to ...

Mumbai: Ranbaxy Laboratories Ltd has reached an agreement with GlaxoSmithKline (GSK) to call off a patent suit in the US with regard to Valtrex (valacyclovir hydrochloride tablets). The lawsuit in the ...